Podcasts about Journal club

Send us a textIn this Journal Club episode, Ben and Daphna review a large national cohort study examining the association between antenatal corticosteroid exposure and survival in extremely preterm infants born between 21 and 24 weeks' gestation. They discuss biologic plausibility, practice variation, and the challenges of interpreting retrospective data, while focusing on how these findings may inform counseling and shared decision-making at the margins of viability.----The Effects of Antenatal Corticosteroids on Extremely Premature Neonates Born between 21 and 24 Weeks. Yao R, Tritch N, Vedhanayagam K, Ali N, Reimche-Vu H, Gedestad I, Karageuzian S, Contag S.Am J Perinatol. 2025 Nov 6. doi: 10.1055/a-2722-8107. Online ahead of print. PMID: 41086871Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Send us a textBen and Daphna review the ICAF randomized clinical trial evaluating extended caffeine therapy in preterm infants and its impact on intermittent hypoxia through 41 weeks postmenstrual age. They discuss the study design, oximetry outcomes across multiple saturation thresholds, inflammatory biomarkers including TNF-α, and clinically relevant safety signals such as oxygen restart rates, length of stay, and weight gain. The conversation focuses on what intermittent hypoxia may mean for ongoing risk, and whether a targeted subgroup of infants might benefit from extending caffeine beyond traditional stopping points.----Intermittent hypoxia and caffeine in infants born preterm: the ICAF Randomized Clinical Trial. Eichenwald E, Corwin M, McEntire B, Knoblach S, Limperopoulos C, Kapse K, Kerr S, Heeren TC, Ikponmwonba C, Hunt CE; ICAF Study Group.Arch Dis Child Fetal Neonatal Ed. 2025 Nov 24:fetalneonatal-2025-329230. doi: 10.1136/archdischild-2025-329230. Online ahead of print.PMID: 41285561Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

In this episode of the Award-winning PRS Journal Club Podcast, 2026 Resident Ambassadors to the PRS Editorial Board – Lucas Harrison, Christopher Kalmar, and Priyanka Naidu- and special guest, Shai Rozen, MD, discuss the following articles from the January 2026 issue: "The Efficacy of Flap Debulking after Facial Reanimation Surgery to Enhance Facial Symmetry" by Weiss, Fricke, Hohenstein, et al. Read the article for FREE: https://bit.ly/FlapDebulk Special guest, Shai Rozen is Professor and Vice-Chairman in the Department of Plastic Surgery at the University of Texas Southwestern Medical Center and Director of the Facial Reanimation Program, specializing in treating patients with facial paralysis. He completed both general surgery and plastic surgery training at Johns Hopkins, followed by fellowships in both craniofacial and peripheral nerve surgery.  READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCJan26Collection The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS.

Send us a textIn this Journal Club episode, Ben and Daphna review a salient study from JAMA Network Open examining outcomes of infants born at 21 weeks' gestation at the University of Iowa. They walk through resuscitation practices, early physiologic challenges, survival trends, and short-term developmental outcomes, while placing the data in the broader context of shifting limits of viability. The discussion highlights both cautious optimism and the many unanswered questions that remain as neonatology continues to push the boundaries of what is possible.----Outcomes of Infants Born at 21 Weeks' Gestational Age. Hyland RM, Mat HD, Boly TJ, Thomas BJ, Stanford AH, Harmon HM, Bermick JR, Davila RC, Colaizy TT, Dagle JM, Klein JM, Greiner AL, Bell EF, McNamara PJ; University of Iowa Neonatology Program.JAMA Netw Open. 2025 Dec 1;8(12):e2548211. doi:10.1001/jamanetworkopen.2025.48211.PMID: 41385227 Free PMC article.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Featuring an interview with Dr Scott Kopetz, including the following topics: Circulating tumor DNA (ctDNA)-based molecular residual disease (MRD) and survival among patients with resectable colorectal cancer (CRC) in the CIRCULATE-Japan GALAXY trial (0:00) ctDNA for detection of MRD in patients with CRC in the BESPOKE CRC and INTERCEPT trials (3:11) Clinical utility of including ctDNA monitoring in standard CRC surveillance (11:11) ctDNA analysis guiding adjuvant therapy for CRC in the DYNAMIC and CIRCULATE-North America trials (15:52) CME information and select publications

Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston discusses recent developments with circulating tumor DNA assays in the management of colorectal cancer.CME information and select publications here.

Send us a textIn this Journal Club episode, Ben and Daphna review a major randomized clinical trial published in JAMA comparing expectant management with active pharmacologic treatment of patent ductus arteriosus in preterm infants. They walk through the trial design, inclusion criteria, and outcomes, highlighting the unexpected survival difference favoring expectant management despite similar rates of bronchopulmonary dysplasia. The discussion explores the implications for bedside decision-making, the limitations of PDA-focused strategies, and the need for a more physiologic, patient-centered approach to ductal management in extremely preterm infants.----Expectant Management vs Medication for Patent Ductus Arteriosus in Preterm Infants: The PDA Randomized Clinical Trial. Laughon MM, Thomas SM, Watterberg KL, Kennedy KA, Keszler M, Ambalavanan N, Davis AS, Slaughter JL, Guillet R, Colaizy TT, Cotten CM, Dhawan MA, Bose CL, Talbert J, Smucny S, Benitz WE, Rysavy MA, Ohls RK, Baserga MC, DeMauro SB, Jaleel M, Jackson WM, Carlo WA, Puopolo KM, Hibbs AM, Katheria A, Sánchez PJ, D'Angio CT, Patel RM, Johnson BA, Chock VY, Bhatt AJ, Merhar SL, Moore R, Laptook AR, Ghavam S, Fuller J, Vyas-Read S, Kicklighter SD, Steinbrekera B, Anderson K, Reynolds AM, Wyckoff MH, Montoya C, Das A, Do B, Chang S, Higgins RD, Walsh MC; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network.JAMA. 2025 Dec 9:e2523330. doi: 10.1001/jama.2025.23330. Online ahead of print.PMID: 41364689Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

E se tivéssemos uma maneira de prever quais pacientes com X(T) terão recidiva precoce após a cirurgia?Foi isso que um grupo de pesquisadores chineses tentou descobrir através desse estudo publicado no American Journal of Ophthalmology em 2023.E a Dra Iluska Agra, da Universidade Federal da Bahia, estudou esse artigo para nos trazer seus principais achados de uma maneira bem didática!Vamos juntos?Link para o artigo https://www.ajo.com/article/S0002-9394(23)00094-6/abstractReferência: Wang Z, Li T, Zuo X, Liu L, Zhang T, Leng Z, Chen X, Liu H. Preoperative and Postoperative Clinical Factors in Predicting the Early Recurrence Risk of Intermittent Exotropia After Surgery. Am J Ophthalmol. 2023 Jul;251:115-125. doi: 10.1016/j.ajo.2023.02.024. Epub 2023 Mar 10. PMID: 36906096.

Send us a textEpisódio 69 — Controvérsias sobre persistência do canal arterial em prematuros: o que a evidência realmente mostraA persistência do canal arterial em prematuros segue sendo um dos temas mais debatidos da neonatologia moderna — e talvez um dos mais desafiadores. Durante anos, aprendemos que identificar e fechar o canal era sinônimo de fazer o “certo”. Mas, à medida que grandes ensaios clínicos foram publicados, essa certeza começou a ruir.Neste episódio especial, mergulhamos nas principais evidências que mudaram — e continuam mudando — a forma como pensamos o canal arterial: por que ele se mantém aberto, o que realmente acontece do ponto de vista hemodinâmico, quando (e se) devemos intervir, e quais desfechos importam de verdade.Revisitamos estudos marcantes, discutimos suas perguntas, métodos, resultados e implicações práticas, trazendo o olhar crítico para o contexto das UTIs neonatais brasileiras — onde os recursos, as rotinas e os desafios nem sempre são os mesmos dos grandes centros de pesquisa.Mais do que procurar respostas definitivas, o episódio convida à reflexão: o canal arterial é vilão, espectador ou marcador da imaturidade extrema? Estamos ajudando nossos pacientes quando intervimos precocemente — ou apenas fechando um número no ecocardiograma?1. Baby OSCAR: Trial of Selective Early Treatment of Patent Ductus Arteriosus with Ibuprofen  https://www.nejm.org/doi/full/10.1056/NEJMoa23055822. Two-year outcomes after selective early treatment of patent ductus arteriosus with ibuprofen in preterm babies: follow-up of Baby-OSCAR–a randomised controlled trial - https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(25)00356-6/fulltext3. BeNeDUCTUS: Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus https://www.nejm.org/doi/full/10.1056/NEJMoa22074184. Expectant Management vs Medication for Patent Ductus Arteriosus in Preterm Infants - The PDA Randomized Clinical Trial https://jamanetwork.com/journals/jama/article-abstract/2842696?utm_campaign=articlePDF&utm_medium=articlePDFlink&utm_source=articlePDF&utm_content=jama.2025.233305. TIPP Trial: Long-Term Effects of Indomethacin Prophylaxis in Extremely-Low-Birth-Weight Infants https://www.nejm.org/doi/full/10.1056/NEJM2001062834426026. Current approaches to the patent ductus arteriosus: Implications for pulmonary morbidities https://pubmed.ncbi.nlm.nih.gov/40450478/ Não esqueça: você pode ter acesso aos artigos do nosso Journal Club no nosso site: https://www.the-incubator.org/podcast-1 Lembrando que o Podcast está no Instagram, @incubadora.podcast, onde a gente posta as figuras e tabelas de alguns artigos. Se estiver gostando do nosso Podcast, por favor dedique um pouquinho do seu tempo para deixar sua avaliação no seu aplicativo favorito e compartilhe com seus colegas. Isso é importante para a gente poder continuar produzindo os episódios. O nosso objetivo é democratizar a informação. Se quiser entrar em contato, nos mandar sugestões, comentários, críticas e elogios, manda um e-mail pra gente: incubadora@the-incubator.org

Zum Jahresende haben wir was ganz Besonderes für euch: Wir haben uns live und in Farbe im schönen Sauerland getroffen um diese Folge für euch aufzunehmen. Wie jedes Jahr gibt es wieder einen XXXXL-Journalclub für euch. Außerdem stellt Dana die Neuerungen der Reanimationsguidelines 2025 vor und Anna-Lena spricht über das wahnsinnig spannende und relevante Thema „Gendermedizin in der Anästhesie“. Wir […] Der Beitrag Hauptfolge Dezember – Folge 84 erschien zuerst auf pin-up-docs - don't panic.

Join us for the December edition of the Simulcast Journal Club, hosted by Vic Brazil and Ben Symon. In this episode:  Simulation for older adults health assessments, training for orthopaedic technical skills, resolving latent safety threats, and a call for manuscripts in the theme of translational simulation.    The December papers  Larsen BH et al. Simulation training for holistic and systematic health needs assessments of older adults: a qualitative study. Adv Simul. 2025;10:64.   Gilmore C, Napier R, Ballard J. Transforming learning in trauma and orthopaedics: a proof-of-concept study on a novel 3D printed model with real-time intra-operative radiographic feedback. J Healthc Simul. 2025; Published 05 December 2025.   Weller J, et al. Resolving latent safety threats identified through in situ simulation: a multicentre mixed-methods study. Adv Simul. 2025; [Article in Press].   Brazil V, Eller S, Bajaj K. Reimagining simulation for quality and safety in healthcare: connecting paradigms, methods, and communities. Adv Simul. 2025;10:63.     Another great month on Simulcast.  Happy listening and happy holidays    

Send us a textWelcome back to The Oncology Journal Club podcast — our favourite episode of the year!Hosted by Professor Craig Underhill, Dr Kate Clarke and Professor Christopher Jackson.The team reflect on the achievements of 2025, highlighting key developments, initiatives and papers that have made — and will continue to make — a real impact on clinical practice. As CJ says, it's a privilege to work in what is the “single most innovative and thoughtful field in all of medicine” — and we are indeed lucky to have our brains tickled every month by this wonderful podcast.And of course, it wouldn't be OJC without some laughs and a few naughty jokes — and this year, we even have the inaugural OJC Christmas haiku!Thank you for listening. We hope you enjoy the final episode of The Oncology Journal Club for 2025.Visit oncologynetwork.com.au for Show Notes and more information. Proudly produced by the team at the Oncology Network

Send us a textIn dieser Weihnachtsfolge nehmen wir die BMJ Christmas Edition 2025 unter die Lupe – eine Ausgabe, die weniger auf Skurrilität setzt als auf kritische Selbstbeobachtung der Wissenschaft.Wir sprechen über sprachliche Unschärfen, politischen Anpassungsdruck, strukturelle Parallelen zwischen ärztlicher Kommunikation und KI-Halluzinationen, den Einfluss von Big Tech auf medizinische Versorgung, Defizite in der medizinischen Lehre und die ambivalente Rolle von KI-Chatbots in der Einsamkeitskrise.Besprochen werden folgende Beiträge aus dem British Medical Journal:“How recent is recent? Retrospective analysis of suspiciously timeless citations”Alejandro Díez-Vidal, Jose R Arribas“Changes in diversity language in National Institutes of Health grant awards”Neil Mehta, Anupam B. Jena“Parallel pressures: the common roots of doctor bullshit and large language model hallucinations”Trisha Greenhalgh, Brian McMillan, Anna P. Cox“Reclaiming human care from surveillance capitalism”Victor Montori et al.“Seven alternatives to evidence based medical education”Sabine Drossard, Anja Härtl, Johanna Büchel“AI chatbots and the loneliness crisis”Susan C. Shelmerdine, Matthew M. NourEine Episode über Sprache als Machtinstrument, über Systeme, die Antworten erzwingen – und über die Frage, was in Medizin und Wissenschaft eigentlich noch als Care gelten soll.Das Team von HAINS Talk sagt DANKE für 16.000 Downloads in 2025! Wir wünschen allen Hörerinnen und Hörern frohe Weihnachten, ruhige Festtage, einen guten Rutsch und ein gesundes und erfolgreiches 2026! Wir starten am 13. Januar wieder in ein neues Podcast-Jahr!

Carepoint Journal Club is a quarterly series with discussions about a medical topic, brought to you by Carepoint's Emergency Physicians.

In this episode of the Award-winning PRS Journal Club Podcast, 2026 Resident Ambassadors to the PRS Editorial Board – Lucas Harrison, Christopher Kalmar, and Priyanka Naidu- and special guest, Shai Rozen, MD, discuss the following articles from the January 2026 issue:   "The Efficacy of Flap Debulking after Facial Reanimation Surgery to Enhance Facial Symmetry" by Weiss, Fricke, Hohenstein, et al.   "The Natural Progression of Synkinesis" by Rail, Bhatia, Dragun, et al.   "Extended Sural Nerve Harvest: A Technique to Gain Additional Graft Length" by Millesi, Gates-Tanzer, Felzen, et al.   Special guest, Shai Rozen is Professor and Vice-Chairman in the Department of Plastic Surgery at the University of Texas Southwestern Medical Center and Director of the Facial Reanimation Program, specializing in treating patients with facial paralysis. He completed both general surgery and plastic surgery training at Johns Hopkins, followed by fellowships in both craniofacial and peripheral nerve surgery.    READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCJan26Collection   The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS.

Send us a textIn this Journal Club episode, Ben and Daphna review five recent studies with practical implications for neonatal care. The FEED1 trial examines whether starting full milk feeds from day one is safe in 30-32 week preterm infants, finding no difference in length of stay compared to gradual feeding but fewer central line days. A brief communication from UAB explores high-volume feeding strategies (≥170 ml/kg/day) and their impact on body composition in very preterm infants.The hosts discuss a mannequin study from Italy measuring forces applied during intubation with different laryngoscope types and bed heights, revealing that video laryngoscopy at navel height applies the lowest forces—contrary to most clinicians' perceptions.A large Japanese cohort study highlights the association between maternal psychological distress and neurodevelopmental delays, with postpartum distress showing stronger effects than prenatal stress. Finally, analysis of Neonatal Research Network data identifies predictors of early cord clamping in extremely preterm infants, with lack of magnesium sulfate, cesarean delivery, and antepartum hemorrhage being key factors.The episode wraps with reminders about upcoming conferences, including the Delphi Conference in Fort Lauderdale in January 2026.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Send us a textFull exclusively enteral fluids from day 1 versus gradual feeding in preterm infants (FEED1): a open-label, parallel-group, multicentre, randomised, superiority trial.Ojha S, Mitchell EJ, Johnson MJ, Gale C, McGuire W, Oddie S, Hall SS, Meakin G, Anderson J, Partlet C, Su Y, Johnson S, Walker KF, Ogollah R, Mistry H, Naghdi S, Montgomery A, Dorling J; FEED1 collaborative.Lancet Child Adolesc Health. 2025 Dec;9(12):827-836. doi: 10.1016/S2352-4642(25)00271-8. Epub 2025 Oct 17.PMID: 41115446 Free article. Clinical Trial.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Send us a textEarly body composition outcomes of infants born very preterm and receiving high volume, human milk feedings (≥170 ml/kg/day) before postnatal day 14.Gunawan E, Molleti M, Salas AA.J Perinatol. 2025 Oct 31. doi: 10.1038/s41372-025-02469-w. Online ahead of print.PMID: 41174086 No abstract available.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Send us a textApplied forces during neonatal intubation with direct and video laryngoscopy at different bed elevations: a randomized crossover manikin study.Cavallin F, Pasquali G, Maglio S, Villani PE, Menciassi A, Tognarelli S, Trevisanuto D.Eur J Pediatr. 2025 Nov 5;184(12):732. doi: 10.1007/s00431-025-06524-8.PMID: 41191125 Free PMC article. Clinical Trial.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Send us a textTreatment of Hypotension of Prematurity: a randomised trial.Alderliesten T, Arasteh E, van Alphen A, Groenendaal F, Dudink J, Benders MJ, van Bel F, Lemmers P. Arch Dis Child Fetal Neonatal Ed. 2025 Dec 15;111(1):F60-F66. doi: 10.1136/archdischild-2024-328253.PMID: 40413017 Clinical Trial.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Send us a textMaternal Psychological Distress Before and After Childbirth and Neurodevelopmental Delay in Toddlers.Matsumura K, Tanaka T, Kuroda M, Tsuchida A, Hatakeyama T, Kasamatsu H, Inadera H; Japan Environment and Children's Study Group.JAMA Netw Open. 2025 Oct 1;8(10):e2540907. doi: 10.1001/jamanetworkopen.2025.40907.PMID: 41171271 Free PMC article.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Send us a textAntenatal Prediction of Early Cord Clamping among Infants Born Extremely Preterm.Katheria A, Dorner RA, Grobman W, Rysavy MA, Koo J, Wyckoff MH, Sandoval G, DeMauro SB, Das A, Lee HC, Cotten M, Calvo L, Saha S; Eunice Kennedy Schriver National Institute of Child Health and Human Development Neonatal Research Network.J Pediatr. 2025 Oct 31:114878. doi: 10.1016/j.jpeds.2025.114878. Online ahead of print.PMID: 41177398Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

How do we know when a retina fellow is truly ready for independent surgery? Nikisha Kothari, MD, moderates a discussion with Jesse Sengillo, MD, and Nicholas Farber, MD, about a new survey study comparing perspectives from fellowship program directors and recent graduates on surgical volumes, teaching tools, autonomy, and competency benchmarks. The group explores areas of agreement, gaps in current training, and the push for more systematic assessment models in retina training.

In this episode of the Award-winning PRS Journal Club Podcast, 2025 Resident Ambassadors to the PRS Editorial Board – Christopher Kalmar, Ilana Margulies, and Amanda Sergesketter- and special guest, Bradley Calobrace, MD, discuss the following articles from the December 2025 issue: "Complications following Primary Implant-Based Gluteal Augmentation: A Systematic Review and Meta-Analysis" by Elsaftawy, Bonczar, Jagosz, et al. Read the article for FREE: https://bit.ly/ImplantGlutealAug Special guest, Dr. Calobrace is a nationally recognized plastic surgeon, an accomplished researcher, and a trusted educator whose work has shaped best practices in breast surgery and aesthetic medicine. Dr. Calobrace is a graduate of Indiana University Medical School and completed residencies in both general surgery and plastic surgery at the University of Southern California in Los Angeles. Subsequently, he completed a cosmetic and breast surgery fellowship with Dr. Pat Maxwell and began practice in Louisville, Kentucky. Although most known for aesthetic breast surgery nationally and internationally, Dr. Calobrace has a thriving aesthetic practice and fellowship in aesthetic surgery comprising an equal mix of breast, body, and facial aesthetic surgery. READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCDec25Collection The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS.

This week we drop a journal club extravaganza! Should we do away with the A-Line? Is Bicarb a sure-fire way to treat metabolic acidosis in the setting of AKI? What about selective decontamination and all that capillary refill business!? We tackle all these topics through thoughtful journal discussion, provide our $0.02 and a little witty repartee, of course! Check it out and let us know what you think! Hosted on Acast. See acast.com/privacy for more information.

Found My Fitness - Rhonda Patrick: Read the notes at at podcastnotes.org. Don't forget to subscribe for free to our newsletter, the top 10 ideas of the week, every Monday --------- Get access to more than 200 episodes of my premium podcast (The Aliquot) when you sign up as a FoundMyFitness Premium Member Download my "How to Train According to the Experts" guide One minute of vigorous exercise may be worth up to ten minutes of "moderate" cardio for extending lifespan and preventing chronic disease. In this Journal Club episode, Rhonda Patrick, PhD and endurance athlete Brady Holmer dissect a new Nature Communications study of more than 70,000 adults showing that vigorous intensity is roughly 4–10x more potent than moderate activity for reducing all-cause mortality, cardiovascular events, type 2 diabetes, and cancer outcomes—far beyond the long-standing 1:2 rule embedded in global exercise guidelines. Timestamps: (00:00) Introduction (07:01) What exactly is the 1:2 rule for exercise intensity? (08:18) Calorie burn vs. longevity—origins of the 1:2 rule (11:15) What counts as 'vigorous' exercise, really? (13:35) Where the exercise guidelines fall short (14:19) Can your wearable predict disease risk years in advance? (20:11) Is vigorous activity easier to achieve than people think? (22:47) How researchers avoided the 'healthy user bias' (23:59) Health equivalence ratio—a better way to measure exercise benefits? (25:45) Is vigorous exercise truly 4–10x more effective? (29:55) Can one vigorous minute match an hour of gentle walking? (32:02) Why vigorous activity—not gentle—offers dose-dependent benefits (33:50) Is vigorous exercise 5x better at preventing heart attacks & strokes? (34:24) Why vigorous activity stands out for cancer prevention (34:59) Does zone 2 qualify as vigorous exercise? (36:11) Dose-response comparison—vigorous vs. moderate vs. light activity (37:22) Is vigorous exercise the secret to younger arteries? (43:15) Why aging hearts need intensity (46:09) Can vigorous exercise halt your VO₂ max decline? (47:26) Why moderate exercise alone might not improve VO₂ max (49:21) Is vigorous exercise 10x more powerful at preventing diabetes? (55:48) Mitochondrial biogenesis—why intensity is essential (58:40) Can you directly measure mitochondrial health? (1:00:57) Does vigorous exercise kill circulating tumor cells? (1:07:15) Why vigorous intensity triggers beneficial hormone changes (1:08:05) Can vigorous activity protect older adults from falls? (1:12:36) Does vigorous exercise combat inflammation? (1:14:29) Is high-intensity training the key to a younger brain? (1:16:01) Is vigorous exercise more powerful than we realized? (1:17:50) Can the benefits of vigorous exercise fit into a pill? (1:19:08) How small doses of intensity might extend your lifespan (1:23:15) Do short bursts of vigorous movement match full workouts? (1:27:26) Why your wearable might undervalue short vigorous bouts (1:30:06) Can planned micro-workouts replace traditional gym sessions? (1:35:10) Why exercise guidelines urgently need updating (1:46:35) Does light activity still offer real benefits? (1:49:04) Is vigorous exercise safe for older adults? (1:53:28) Are high-intensity workouts detrimental to female hormones? (1:58:02) Safe vigorous exercise options—even with chronic illness (1:59:05) The 80/20 rule for balancing intensity and recovery (2:01:30) Inside Brady's routine—how much vigorous exercise is optimal? (2:05:17) Can vigorous activity boost kids' brainpower (and grades)? (2:08:14) Are we significantly underestimating vigorous exercise benefits? (2:10:03) Why chasing steps isn't the answer Show notes are available by clicking here Watch this episode on YouTube

Hosts: Bobbi Conner & Topher Conlan Guest: Sam Zolkiewicz Topic: Review of lily toxicity in cats generally, including a discussion of the article: Lam J, Hess RS, and Reineke EL. Prevalence of acute kidney injury and outcome in cats treated as inpatients versus outpatients following lily exposure. J Am Vet Med Assoc. 2025;263:41-46.

Send us a textNeste episódio especial do podcast, Mariana e Marôla discutem a importância da nutrição neonatal, abordando temas como o crescimento e desenvolvimento de bebês prematuros, a necessidade de acompanhamento rigoroso após a alta da UTI neonatal, a composição nutricional e a fortificação do leite humano, além do impacto da alimentação enteral precoce na saúde dos recém-nascidos. Os estudos enfatizam a importância de intervenções nutricionais adequadas e a necessidade de monitoramento contínuo para garantir o melhor desenvolvimento possível para esses bebês.1. Tamanho e Crescimento Após a Alta da UTIN em Bebês de Extremo Baixo Peso ou Extremamente Prematuros https://publications.aap.org/pediatrics/article-abstract/156/4/e2025071784/203460/Size-and-Growth-After-NICU-Discharge-in-Extremely?redirectedFrom=PDF2. Oferta de Leite Materno da Própria Mãe nas Primeiras 12 Semanas de Vida https://jamanetwork.com/journals/jamanetworkopen/fullarticle/28310123. Tempo até Dieta Enteral Plena e Sepse Tardia em Prematuros Extremos https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2841446?utm_campaign=articlePDF&utm_medium=articlePDFlink&utm_source=articlePDF&utm_content=jamanetworkopen.2025.439404. Crescimento e Nerodesenvolvimento a Longo Prazo de Prematuros Extremos Randomizados para Dieta com LM Fortificado e Enriqecido com Suplemento Protéico https://www.nature.com/articles/s41390-025-04354-wnutrição neonatal, crescimento prematuro, acompanhamento pós-alta, alimentação enteral, fortificação do leite, sepsis neonatal, neurodesenvolvimento Não esqueça: você pode ter acesso aos artigos do nosso Journal Club no nosso site: https://www.the-incubator.org/podcast-1 Lembrando que o Podcast está no Instagram, @incubadora.podcast, onde a gente posta as figuras e tabelas de alguns artigos. Se estiver gostando do nosso Podcast, por favor dedique um pouquinho do seu tempo para deixar sua avaliação no seu aplicativo favorito e compartilhe com seus colegas. Isso é importante para a gente poder continuar produzindo os episódios. O nosso objetivo é democratizar a informação. Se quiser entrar em contato, nos mandar sugestões, comentários, críticas e elogios, manda um e-mail pra gente: incubadora@the-incubator.org

Episode 39 of the ESCRS Eye Journal Club with Artemis Matsou, Alfredo Borgia and Victoria Till was held on 25th November 2025 The guest experts are Claudette Abela-Formanek and Florian Kretz who discuss the following paper: 3-Year Comparison of Two Mix-and-Match Strategies: Enhanced Monofocal and Trifocal Vs Enhanced Monofocal and Trifocal EDOF IDOLs

In this episode of the Award-winning PRS Journal Club Podcast, 2025 Resident Ambassadors to the PRS Editorial Board – Christopher Kalmar, Ilana Margulies, and Amanda Sergesketter- and special guest, Bradley Calobrace, MD, discuss the following articles from the December 2025 issue: "A Modified Bimuscular Flap Technique for Breast Augmentation: Does Extra Muscle Support Enhance the Stability of Smooth Implants?" by Xia, Xie, Su, et al. Read the article for FREE: https://bit.ly/BimuscularFlap Special guest, Dr. Calobrace is a nationally recognized plastic surgeon, an accomplished researcher, and a trusted educator whose work has shaped best practices in breast surgery and aesthetic medicine. Dr. Calobrace is a graduate of Indiana University Medical School and completed residencies in both general surgery and plastic surgery at the University of Southern California in Los Angeles. Subsequently, he completed a cosmetic and breast surgery fellowship with Dr. Pat Maxwell and began practice in Louisville, Kentucky. Although most known for aesthetic breast surgery nationally and internationally, Dr. Calobrace has a thriving aesthetic practice and fellowship in aesthetic surgery comprising an equal mix of breast, body, and facial aesthetic surgery.  READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCDec25Collection The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS.

Send us a textWelcome to The Oncology Journal Club Podcast Series 3Hosted by Professor Craig Underhill, Dr Kate Clarke & Professor Christopher Jackson | Proudly produced by The Oncology NetworkWelcome back to The Oncology Journal Club podcast, your essential dose of the latest oncology research, expert analysis and our trademark blend of healthy scepticism and bad jokes.Hosted by Professor Craig Underhill, Dr Kate Clarke and Professor Christopher Jackson.This week's episode really does contain multitudes, with an incredibly eclectic mix of papers.Craig looks at the effectiveness of cancer control measures and optimising drug dosages.Kate talks us through interactions between solid neoplasms and the microbiome and shares a curious paper on extra virgin olive oil.CJ tackles a sobering paper on substandard anticancer medications and what lessons can be learnt from KEYNOTE-585 and Matterhorn in gastric cancer.We've a great selection of Quick Bites and a heartfelt discussion about taboo thoughts and the challenges carers of people with brain cancer face.To learn more about The Oncology Network, subscribe to our free weekly Newsletter and listen to other fantastic podcasts, visit our website: www.oncologynetwork.com.au. You'll also find the Show Notes on the website with links to papers, a transcript and bios of our hosts.

Get access to more than 200 episodes of my premium podcast (The Aliquot) when you sign up as a FoundMyFitness Premium Member Download my "How to Train According to the Experts" guide One minute of vigorous exercise may be worth up to ten minutes of "moderate" cardio for extending lifespan and preventing chronic disease. In this Journal Club episode, Rhonda Patrick, PhD and endurance athlete Brady Holmer dissect a new Nature Communications study of more than 70,000 adults showing that vigorous intensity is roughly 4–10x more potent than moderate activity for reducing all-cause mortality, cardiovascular events, type 2 diabetes, and cancer outcomes—far beyond the long-standing 1:2 rule embedded in global exercise guidelines. Timestamps: (00:00) Introduction (07:01) What exactly is the 1:2 rule for exercise intensity? (08:18) Calorie burn vs. longevity—origins of the 1:2 rule (11:15) What counts as 'vigorous' exercise, really? (13:35) Where the exercise guidelines fall short (14:19) Can your wearable predict disease risk years in advance? (20:11) Is vigorous activity easier to achieve than people think? (22:47) How researchers avoided the 'healthy user bias' (23:59) Health equivalence ratio—a better way to measure exercise benefits? (25:45) Is vigorous exercise truly 4–10x more effective? (29:55) Can one vigorous minute match an hour of gentle walking? (32:02) Why vigorous activity—not gentle—offers dose-dependent benefits (33:50) Is vigorous exercise 5x better at preventing heart attacks & strokes? (34:24) Why vigorous activity stands out for cancer prevention (34:59) Does zone 2 qualify as vigorous exercise? (36:11) Dose-response comparison—vigorous vs. moderate vs. light activity (37:22) Is vigorous exercise the secret to younger arteries? (43:15) Why aging hearts need intensity (46:09) Can vigorous exercise halt your VO₂ max decline? (47:26) Why moderate exercise alone might not improve VO₂ max (49:21) Is vigorous exercise 10x more powerful at preventing diabetes? (55:48) Mitochondrial biogenesis—why intensity is essential (58:40) Can you directly measure mitochondrial health? (1:00:57) Does vigorous exercise kill circulating tumor cells? (1:07:15) Why vigorous intensity triggers beneficial hormone changes (1:08:05) Can vigorous activity protect older adults from falls? (1:12:36) Does vigorous exercise combat inflammation? (1:14:29) Is high-intensity training the key to a younger brain? (1:16:01) Is vigorous exercise more powerful than we realized? (1:17:50) Can the benefits of vigorous exercise fit into a pill? (1:19:08) How small doses of intensity might extend your lifespan (1:23:15) Do short bursts of vigorous movement match full workouts? (1:27:26) Why your wearable might undervalue short vigorous bouts (1:30:06) Can planned micro-workouts replace traditional gym sessions? (1:35:10) Why exercise guidelines urgently need updating (1:46:35) Does light activity still offer real benefits? (1:49:04) Is vigorous exercise safe for older adults? (1:53:28) Are high-intensity workouts detrimental to female hormones? (1:58:02) Safe vigorous exercise options—even with chronic illness (1:59:05) The 80/20 rule for balancing intensity and recovery (2:01:30) Inside Brady's routine—how much vigorous exercise is optimal? (2:05:17) Can vigorous activity boost kids' brainpower (and grades)? (2:08:14) Are we significantly underestimating vigorous exercise benefits? (2:10:03) Why chasing steps isn't the answer Show notes are available by clicking here Watch this episode on YouTube

Justin joins me for the last Journal Jam for the year -  we cover a lot of ground from Andromeda to the pulmonary physiology of flying rhinoceroses.

In this episode of the Award-winning PRS Journal Club Podcast, 2025 Resident Ambassadors to the PRS Editorial Board – Christopher Kalmar, Ilana Margulies, and Amanda Sergesketter- and special guest, Bradley Calobrace, MD, discuss the following articles from the December 2025 issue: "Single-Dose versus 24-Hour Antibiotic Prophylaxis in Reduction Mammaplasty: A Randomized Controlled Trial" by Veiga, Garcia, Veiga-Filho, et al. Read the article for FREE: https://bit.ly/SingleDose24 Special guest, Dr. Calobrace is a nationally recognized plastic surgeon, an accomplished researcher, and a trusted educator whose work has shaped best practices in breast surgery and aesthetic medicine. Dr. Calobrace is a graduate of Indiana University Medical School and completed residencies in both general surgery and plastic surgery at the University of Southern California in Los Angeles. Subsequently, he completed a cosmetic and breast surgery fellowship with Dr. Pat Maxwell and began practice in Louisville, Kentucky. Although most known for aesthetic breast surgery nationally and internationally, Dr. Calobrace has a thriving aesthetic practice and fellowship in aesthetic surgery comprising an equal mix of breast, body, and facial aesthetic surgery. READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCDec25Collection The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS.

The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:1. FDA change in Boxed Warning Label for Hormone Replacement Therapy.  Discussion by:Guest:Anupriya Grover Wenk, DOFaculty - Family Medicine Residency ProgramJefferson Health - Abington2. Evolocumab in Patients without a Previous Myocardial Infarction or Stroke – The New England Journal of Medicine 2025. Discussion by:Guest:Neil Skolnik, MD Professor of Family and Community MedicineSidney  Kimmel  Medical College Thomas Jefferson University Associate Director - Family Medicine Residency Program Jefferson Health – Abington3. AI-Powered Lifestyle Intervention vs Human Coaching in the Diabetes Prevention Program – JAMA. Discussion by:Guest:Neil Skolnik, MDProfessor of Family and Community MedicineSidney  Kimmel  Medical College Thomas Jefferson UniversityAssociate Director - Family Medicine Residency ProgramJefferson Health – Abington4. Incremental effect of healthy lifestyle habits when taking GLP-1 RA medications on Cardiac Risk Reduction.  Discussion by:Guest:Joe Gonella, MDResident– Family Medicine Residency ProgramJefferson Health – AbingtonMedical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. This Podcast Episode does not offer CME/CE Credit. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Episode 4 of our monthly GU Cast Journal Club and today we focus on two important papers in prostate cancer diagnostics and bladder cancer surgery. The PRECISION NEJM paper 2018 is a landmark publication which defined the role of mpMRI in early detection, and changed practice in many countries. The EB-StaR trial should also change practice after its European Urology 2024 publication, but has it??!We are delighted to welcome back our GU Cast Journal Club Editors, Dr Carlos Delgado (Melbourne, AUS), and Dr Elena Berg (Munich, GER), along with main GU Cast Hosts, Renu Eapen and Declan Murphy. A very lively discussion!! Links to papers below:1. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis NEJM 20182. Transurethral En Bloc Resection Versus Standard Resection of Bladder Tumour: A Randomised, Multicentre, Phase 3 Trial Eur Urol 2024GU Cast Journal Club is supported by our Partner, MSD, through an unrestricted educational grant.Even better on our YouTube channelAbout GU Cast Journal Club:Each month, two papers are discussed, each of which are of importance to the GU Oncology community. These may be recent papers, or occasionally we will chose a classic landmark paper in GU Oncology. The objective is to draw attention to important papers in GU Oncology, and critique these in a robust manner. The key target audience is trainees working in Urology, Medical Oncology, Radiation Oncology, Nuclear Medicine, and diagnostic specialties such as Radiology and Pathology. But any of our regular audience are likely to enjoy this Journal Club series.

ASOPRS Website: Click Here Join our host, Dr. Edith Reshef and esteemed guests Dr. Jonathan Lu, Dr. Seanna Grob, and Dr. Reza Vagefi in their discussion of the September-October issue of OPRS. Topics include utilization of serologic inflammatory markers in predicting orbital cellulitis severity, whether silicone cream is beneficial post-operatively for periorbital surgery, and management of refractive blepharospasm with partial orbicularis myectomy. Listen in to gain insight from our experts!

Send us a textBem-vindos ao episódio 67 de A Incubadora, o seu podcast quinzenal dedicado a democratizar o conhecimento em neonatologia e aproximar profissionais de saúde das melhores evidências científicas disponíveis. Aqui, discutimos de forma clara, crítica e contextualizada os avanços mais recentes da literatura, sempre com foco na prática clínica das UTIs neonatais brasileiras.No episódio de hoje, trazemos quatro artigos que dialogam com temas centrais da assistência ao recém-nascido de alto risco. Começamos explorando uma revisão de escopo publicada no Journal of Perinatology, que analisa o uso da ultrassonografia durante a reanimação neonatal — o NeoSONAR — e descreve como essa tecnologia pode transformar nossa abordagem nos primeiros minutos de vida. https://www.nature.com/articles/s41372-025-02458-zSeguimos com um estudo do Pediatric Research, que investiga o impacto do uso de leite humano doado no desenvolvimento estrutural do cérebro de prematuros muito pequenos, ampliando a discussão sobre nutrição, equidade e neuroproteção. https://www.nature.com/articles/s41390-025-04539-3No terceiro bloco, discutimos um artigo do Journal of Pediatrics que pergunta se é possível otimizar o rastreio da retinopatia da prematuridade através da combinação de escores de risco, reduzindo exames sem comprometer a segurança. https://www.jpeds.com/article/S0022-3476(25)00084-8/abstractE encerramos com uma publicação recente do Acta Paediatrica sobre estratégias para apoiar o contato pele a pele precoce em bebês nascidos entre 22 e 23 semanas — um tema que desafia paradigmas e reforça o potencial transformador do cuidado centrado na família, mesmo nos limites da viabilidade. https://onlinelibrary.wiley.com/doi/10.1111/apa.70255Fique com a gente para mais uma rodada de evidências atualizadas, interpretações cuidadosas e reflexões aplicadas ao nosso cotidiano nas UTIs neonatais. Não esqueça: você pode ter acesso aos artigos do nosso Journal Club no nosso site: https://www.the-incubator.org/podcast-1 Lembrando que o Podcast está no Instagram, @incubadora.podcast, onde a gente posta as figuras e tabelas de alguns artigos. Se estiver gostando do nosso Podcast, por favor dedique um pouquinho do seu tempo para deixar sua avaliação no seu aplicativo favorito e compartilhe com seus colegas. Isso é importante para a gente poder continuar produzindo os episódios. O nosso objetivo é democratizar a informação. Se quiser entrar em contato, nos mandar sugestões, comentários, críticas e elogios, manda um e-mail pra gente: incubadora@the-incubator.org

In this episode of the Award-winning PRS Journal Club Podcast, 2025 Resident Ambassadors to the PRS Editorial Board – Christopher Kalmar, Ilana Margulies, and Amanda Sergesketter- and special guest, Gabriel Del Corral, MD, discuss the following articles from the November 2025 issue: "Venous Thromboembolism Chemoprophylaxis in Plastic Surgery: A Randomized Controlled Trial of Apixaban versus Enoxaparin" by Momeni, Yesantharao, Meyer, et al. Read the article for FREE: https://bit.ly/ApixVSEnoxRCT Special guest, Dr. Gabriel Del Corral is a Professor of Plastic Surgery at MedStar Georgetown University Hospital and the Director of the MedStar Center for Gender Affirmation. He completed his general surgery residency at Main Line Health Jefferson Health System, followed by his plastic surgery residency at Vanderbilt University Medical Center. He then completed a microsurgery fellowship at the University of Pennsylvania. He specializes in both breast reconstruction, as well as head-to-toe and comprehensive gender affirming operations, including facial surgery, top surgery and bottom surgery, and is widely published in all areas of gender affirmation. READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCNov25Collection The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS.

Caudal Epidural Steroid Injection with PRP Case Reports and a Testimonial! Upcoming Training Courses and Services Regional Anesthesia and IV Vascular Access Courses: New York and Detroit locations scheduled Pain Management Board Preparation   Private Coaching Services: Ultrasound guidance Preceptorship Board preparation coaching Contact available via email Info@NRAPpain.org for interested physicians PRP Caudal Epidural Research Review Study Overview: Randomized double-blind controlled pilot study comparing leukocyte-rich PRP versus corticosteroids in caudal epidural space 50 patients randomly assigned to two groups Treatment options: triamcinolone 60mg or leukocyte-rich PRP from 60ml autologous blood Follow-up assessments at 1, 3, and 6 months using VAS and SF-36 surveys Key Findings: Both treatments showed significant pain reduction compared to baseline Steroid group had lower VAS scores at one month PRP group demonstrated superior results at 3 and 6 months PRP group showed significant improvement across all SF-36 domains at 6 months No complications or adverse effects in either group during 6-month follow-up Personal Treatment Experience Dr. Rosenblum received transforaminal PRP injection 9-10 weeks ago Gradual improvement noted from weeks 4-8, with more noticeable benefits from weeks 8-10 Current status: minimal pain (0.5/10) only during weather changes Clinical Practice Philosophy Treatment Approach: Minimalist philosophy focusing on turmeric, PRP, and Pilates Medication Strategy: Low-dose naltrexone as go-to medication, avoiding long-term drugs with side effects Surgical Avoidance: Prioritizing conservative treatments over unnecessary surgical interventions Emergency Department PRP Implementation Case Study Results: Ultrasound-guided caudal epidural steroid injection in ER setting 100% pain resolution achieved Patient discharged directly from ER Cost savings: reduced from $33,000 to $4,800 (approximately $28,000 savings) Training Opportunities: Private training sessions available for ER physicians interested in ultrasound-guided procedures Patient Testimonial Highlights Case Background: Nurse with herniated disc from March, previously considering $30,000 surgery Treatment Outcome: PRP injection completed two months ago with nearly complete pain relief Reduced from multiple pain medications to one Advil daily Eliminated antalgic posture and muscle spasms Returned to full 12-hour hospital shifts without difficulty Overall quality of life restored to normal levels David Rosenblum, MD, currently serves as the Director of Pain Management at Maimonides Medical Center and AABP Integrative Pain Care.  As a member of the Department of Anesthesiology, he is involved in teaching, research, CME activities, and was key faculty in developing the anesthesiology residency's regional anesthesia block rotation, as well as institutional wide acute and chronic pain management protocols to ensure safe and effective pain management. He currently is a managing partner in a multi-physician private pain practice, AABP Integrative Pain Care, located in Brooklyn, NY. He is one of the earliest interventional pain physicians to integrate ultrasound guidance to improve the safety and accuracy of interventional pain procedures.   Awards New York Magazine: Top Doctors: 2016, 2017, 2018, 2021, 2022, 2023, 2024, 2025 Schneps Media: 2015, 2016, 2017, 2019, 2020 Top Doctors New York Metro Area (digital guide): 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023 2025 Schneps Media - Brooklyn Courier Life: 2021, 2022, 2023   Dr. Rosenblum written several book chapters on Peripheral Neuromodulation, Radiofrequency Ablation, and Pharmacology.  He has published numerous noteworthy articles and most recently is developing the ASIPP Guidelines for Peripheral Neuromodulation in the treatment of chronic pain. He has been named several times in NY Magazine's Best Pain Management Doctor List, Nassau County's Best Pain Physician, has appeared on NY1 News, and has made several appearances on XM Radio's Doctor Talk. He currently is lecturing on a national and international level and has partnered with the American Society of Interventional Pain Physicians (ASIPP), American Society of Pain and Neuroscience (ASPN), IASP Mexican Chapter, Eastern Pain Association (EPA), the North American Neuromodulation Society (NANS), World Academy of Pain Medicine United, as well as various other organizations, to support educational events and develop new courses. Since 2008, he has helped over 3000 physicians pass the Pain Management Boards, and has been at the forefront of utilizing ultrasound guidance to perform pain procedures.  He now hosts the PainExam podcast, AnesthesiaExam Podcast, PMRExam Podcasts and uses this platform to promote the safe and effective use of ultrasound in the performance of various procedures such as Peripheral Nerve Stimulation, Caudal Epidurals, Selective Nerve Root Blocks, Cluneal Nerve Blocks, Ganglion impar Blocks, Stellate Ganglion Blocks, Brachial Plexus Blocks, Joint Injections and much more!   Doctor Rosenblum created the NRAP (Neuromodulation Regional Anesthesia and Pain) Academy  and travels to teach various courses focused on Pain Medicine, Regenerative Medicine, Ultrasound Guided Pain Procedures and Regional Anesthesia Techniques.    Dr. Rosenblum is persistent when it comes to eliminating pain and has gained a reputation among his patients for thinking "outside the box" and implements ultrasound guidance to deposit medications, biologics (PRP, Bone Marrow Aspirate, etc.) and Peripheral Nerve Stimulators near pain generators. He is currently treating patients in his great neck and Brooklyn office.  For an appointment go to AABPpain.com or call Brooklyn     718 436 7246 Reference Irvan J. Bubic, Jessica Oswald, Ultrasound-Guided Caudal Epidural Steroid Injection for Back Pain: A Case Report of Successful Emergency Department Management of Radicular Low Back Pain Symptoms, The Journal of Emergency Medicine,Volume 61, Issue 3,2021,Pages 293-297,ISSN 0736-4679 Ruiz‐Lopez, Ricardo, and Yu‐Chuan Tsai. "A randomized double‐blind controlled pilot study comparing leucocyte‐rich platelet‐rich plasma and corticosteroid in caudal epidural injection for complex chronic degenerative spinal pain." Pain Practice 20.6 (2020): 639-646. #prppain #paincme #sciatia #ultrasoundmsk #ultrasoundprp #epidural #nypaindoctor #prppainwindsor

‍ ‍Drs. Akshay Thomas and Sarwar Zahid join for a journal club episode discussion of three recent publications:‍ ‍ ‍ ‍Fellow Eye PVD (https://journals.sagepub.com/doi/full/10.1177/24741264251379842)‍ ‍Syfovre versus Izervay (https://journals.sagepub.com/doi/full/10.1177/24741264251379842)‍ ‍Litigation Involving Intravitreal Injections (https://www.ophthalmologyretina.org/article/S2468-6530(25)00439-7/abstract)‍ ‍ ‍ ‍Disclosures: Dr. Sridhar has consulted for Apellis and Astellas in the past 3 years. ‍ ‍

Join us for the November edition of the Simulcast Journal Club, hosted by Vic Brazil and Ben Symon. In this episode: Sense of presence in sim, connecting human factors and translational simulation, positive deviants in in situ simulation and students portraying patients in simulation. And some serious stats… :-)  The November papers  Chevalier S, et al. ‘It feels like I was there!' A cross-sectional study to understand the sense of presence in simulation, the role of internal factors and simulation modalities.  J Healthc Simul. 2025; https://doi.org/10.54531/QUXY5470  O'Connor P, Byrne D, O'Dea A. Human factors and translational simulation: misunderstandings and potential opportunities. J Healthc Simul. 2025; Published 2 Oct 2025. https://doi.org/10.54531/UYWH1164  Baril L, et al. Uncovering success stories: how to resuscitate in situ simulation initiatives in Canadian emergency departments. Adv Simul. 2025;10:47. https://doi.org/10.1186/s41077-025-00376-w  Dalwood, N., et al.  ‘Acting it out really makes it stick in your brain': Educating students for patient portrayal during peer simulation. Medical Teacher, 2025. 1–15. https://doi.org/10.1080/0142159X.2025.2570820  Another great month on Simulcast.  Happy listening    

In this episode of the Award-winning PRS Journal Club Podcast, 2025 Resident Ambassadors to the PRS Editorial Board – Christopher Kalmar, Ilana Margulies, and Amanda Sergesketter- and special guest, Gabriel Del Corral, MD, discuss the following articles from the November 2025 issue: "Learning Curve for Sensory Preservation after Transgender Mastectomy Using Targeted Nipple-Areola Complex Reinnervation with Direct Nerve Coaptation" by Alston, Remy, Kochheiser, et al. Read the article for FREE: https://bit.ly/TNRCurve Special guest, Dr. Gabriel Del Corral is a Professor of Plastic Surgery at MedStar Georgetown University Hospital and the Director of the MedStar Center for Gender Affirmation. He completed his general surgery residency at Main Line Health Jefferson Health System, followed by his plastic surgery residency at Vanderbilt University Medical Center. He then completed a microsurgery fellowship at the University of Pennsylvania. He specializes in both breast reconstruction, as well as head-to-toe and comprehensive gender affirming operations, including facial surgery, top surgery and bottom surgery, and is widely published in all areas of gender affirmation. READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCNov25Collection The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS.

Featuring an interview with Dr Aaron Lisberg, including the following topics: Prevention and Management of Adverse Events of Special Interest with Datopotamab Deruxtecan (Dato-DXd) (0:00) Rugo H et al. US expert Delphi consensus on the prevention and management of stomatitis in patients treated with datopotamab deruxtecan. Support Care Cancer 2025;33(9):756. Abstract Lisberg A et al. Datopotamab deruxtecan-associated select adverse events: Clinical practices and institutional protocols on prophylaxis, monitoring, and management. Oncologist 2025;[Online ahead of print]. Abstract Meric-Bernstam F et al. Prophylaxis, clinical management, and monitoring of datopotamab deruxtecan-associated oral mucositis/stomatitis. Oncologist 2025;30(3). Abstract Novel Strategies Combining Dato-DXd with Osimertinib (10:44) Lu S et al. TROPION-Lung14: A phase 3 study of osimertinib ± datopotamab deruxtecan (Dato-DXd) as first-line (1L) treatment for patients with EGFR-mutated locally advanced or metastatic (LA/M) non-small cell lung cancer (NSCLC). ASCO 2025;Abstract TPS8647. Nadal E et al. TROPION-Lung15: A phase III study of datopotamab deruxtecan (Dato-DXd) ± osimertinib vs platinum doublet chemotherapy in patients with EGFR-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) and disease progression on prior osimertinib. ELCC 2025;Abstract 124TiP. Intracranial Activity Observed with TROP2-Targeting Antibody-Drug Conjugates (15:14) Felip E et al. Brain metastases and actionable genetic alterations with sacituzumab govitecan versus docetaxel in metastatic non-small cell lung cancer: Subgroups of the phase III EVOKE-01 trial. ELCC 2025;Abstract 13P. Lisberg A et al. Intracranial efficacy of datopotamab deruxtecan (Dato-DXd) in patients (pts) with previously treated advanced/metastatic non-small cell lung cancer (a/m NSCLC) with actionable genomic alterations (AGA): Results from TROPION-Lung05. ASCO 2024;Abstract 8593. Pons-Tostivint E et al. Intracranial efficacy of datopotamab deruxtecan (Dato- DXd) in patients with advanced/metastatic NSCLC in TROPION-Lung01. WCLC 2025;Abstract OA10.01. CME information and select publications

In this episode of the Award-winning PRS Journal Club Podcast, 2025 Resident Ambassadors to the PRS Editorial Board – Christopher Kalmar, Ilana Margulies, and Amanda Sergesketter- and special guest, Gabriel Del Corral, MD, discuss the following articles from the November 2025 issue: "The External Strip and Internal Spreader Graft Combined with Dorsal Preservation Rhinoplasty" by Öztürk. Read the article for FREE: https://bit.ly/ExtRhinoSpreader Special guest, Dr. Gabriel Del Corral is a Professor of Plastic Surgery at MedStar Georgetown University Hospital and the Director of the MedStar Center for Gender Affirmation. He completed his general surgery residency at Main Line Health Jefferson Health System, followed by his plastic surgery residency at Vanderbilt University Medical Center. He then completed a microsurgery fellowship at the University of Pennsylvania. He specializes in both breast reconstruction, as well as head-to-toe and comprehensive gender affirming operations, including facial surgery, top surgery and bottom surgery, and is widely published in all areas of gender affirmation. READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCNov25Collection The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS.

Dr. Jeanne De Lavallaz and Dr. Ramy Doss discuss the results of the  TRANSFORM-AF Trial with expert faculty Dr. Sanjeev Saksena and Dr. Varun Sundaram.   The TRANSFORM-AF trial enrolled 2,510 patients with atrial fibrillation (AF), type 2 diabetes, and obesity across 170 Veterans Affairs hospitals to evaluate the impact of diabetes-dose GLP-1 receptor agonists on AF-related outcomes. Participants were assigned to receive either a GLP-1 receptor agonist, a DPP-IV inhibitor, or a sulfonylurea. The primary composite outcome included AF-related hospitalizations, cardioversions, ablation procedures, and all-cause mortality. Over a median follow-up of 3.2 years, GLP-1 use was associated with a 13% reduction in major AF-related events compared to other therapies. The study population was predominantly male, with a high prevalence of severe obesity (BMI >40 kg/m²) in whom the benefit appeared most pronounced. Notably, the observed benefit occurred despite only modest additional weight loss, suggesting potential non-weight-mediated effects of GLP-1 therapy  This episode was planned in collaboration with  Heart Rhythm TV with mentorship from Dr. Daniel Alyesh and Dr. Mehak Dhande.  CardioNerds Journal Club PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron!

Send us a textIdentifying optimal positive end-expiratory pressure with electrical impedance tomography guidance in severe bronchopulmonary dysplasia.Shui JE, LaVita CJ, Alcala GC, Nichols JH, Jassar RK, Turcu RM, Lerou PH, Cereda MF, Carroll RW, Ribeiro De Santis Santiago R, Berra L.J Perinatol. 2025 Sep 30. doi: 10.1038/s41372-025-02433-8. Online ahead of print.PMID: 41028823Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Send us a textWhat's new in neonatal innovation and research this week?Join Ben and Daphna for a lively Journal Club episode of The Incubator Podcast, recorded after a long NICU day but packed with energy and insight. They begin with an update on the newly released NRP 9th Edition, preview their excitement for the upcoming Delphi Neonatal Innovation Conference, and then dive into five remarkable studies shaping neonatal care.From the use of CARPEDIEM for renal replacement therapy in the tiniest infants to a meta-analysis on high-dose vitamin D supplementation, the hosts explore how evolving evidence can transform bedside care. They examine a novel trial of nebulized nitroglycerin for PPHN, the role of electrical impedance tomography (EIT) in optimizing PEEP for infants with severe BPD, and new insights into NEC risk factors even among exclusively human-milk-fed babies.With their trademark mix of curiosity, humor, and critical reflection, Ben and Daphna make complex studies both understandable and relevant for everyday NICU practice.Stay informed and inspired—listen now, and explore more neonatal research and conference updates at www.the-incubator.org. Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Send us a textInfant Renal Replacement Therapy Using Carpediem™: A Multicenter Observational Cohort Study from the ICONIIC Learning Network.Slagle CL, Vuong KT, Krallman KA, Casey L, Gist KM, Jetton JG, Joseph C, Luckritz K, Martin SD, Morgan J, Merrill KA, Plomaritas K, Ramirez D, Tran CL, Shin HS, Snyder AN, Van Wyk B, Yalon L, Goldstein SL, Menon S.J Pediatr. 2025 Sep 26:114838. doi: 10.1016/j.jpeds.2025.114838. Online ahead of print.PMID: 41016463 Free article.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Send us a textRisk factors associated with the development of necrotizing enterocolitis in preterm infants on an exclusive human milk diet: a single-center case-control study.Ailumerab H, Miller JL, DeShea L, Beasley WH, Chaaban H, Bergner EM.J Perinatol. 2025 Aug 30. doi: 10.1038/s41372-025-02401-2. Online ahead of print.PMID: 40885806Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!